• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Oramed Pharmaceuticals Inc

+ Add to Watchlist

ORMP:US

13.6900 USD 0.1500 1.11%

As of 20:10:00 ET on 04/23/2014.

Snapshot for Oramed Pharmaceuticals Inc (ORMP)

Open: 13.6900 Day's Range: 13.5901 - 14.2100 Volume: 99,947
Previous Close: 13.5400 52wk Range: 5.0000 - 31.7300 1-Yr Rtn: +67.36%

Stock Chart for ORMP

No chart data available.
  • ORMP:US 13.6900
  • 1D
  • 1M
  • 1Y
13.5400
Interactive ORMP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ORMP

Current P/E Ratio (ttm) -
Estimated P/E(08/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5400
Est. EPS (USD) (08/2014) -0.6800
Est. PEG Ratio -
Market Cap (M USD) 136.11
Shares Outstanding (M) 9.94
30 Day Average Volume 230,206
Price/Book (mrq) 14.8943
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/17/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ORMP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ORMP

Oramed Pharmaceuticals, Inc. is a pharmaceutical company focused on the development of oral delivery solution. The Company is developing orally ingestible insulin capsules for the treatment diabetes as well as delivery solutions for other drugs and vaccines.

Nadav KidronPresident/CEOYifat ZommerCFO/Treasurer/Secretary
Miriam KidronChief Medical & Tech OfficerJoshua Hexter "Josh"VP:Business Dev/COO
More Company Profile & Key Executives for ORMP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil